Mr David Swiker is the founder of ORPHA Strategy, recognized expert for accelerating clinical development, marketing authorization, patient, and market access for orphan medicinal products, including neurological rare disorders.

He is the author or of numerous peer-reviewed publications, trainer in clinical outcomes assessments and patient-reported outcomes & real-world evidence.